Maternal engagement in HIV care associated with pediatric viral suppression
1. In this cross-sectional study from sub-Saharan Africa, maternal antiretroviral therapy use and viral load suppression were associated with greater ...
Tag: HIV
Weekly islatravir plus lenacapavir maintains HIV virologic suppression
1. In this randomized controlled trial, once-weekly oral islatravir (ISL) plus lenacapavir (LEN) maintained high rates of HIV-1 virologic suppression ...
Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV
1. In this cohort of women living with HIV (WLWH) in Rwanda, there was an increased risk of delivering a ...
Psychiatric and physical comorbidities continue to be prevalent amongst Canadians living with Human Immunodeficiency Virus
Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study ...
Second-line TAF-based ART improves viral suppression in pediatric HIV
1. In this randomized controlled trial (CHAPAS-4), tenofovir alafenamide fumarate (TAF) with emtricitabine showed superior viral suppression at 96 weeks ...
Alcohol use disorder may be associated with human immunodeficiency virus
Alcohol Use Disorder Diagnoses Among Individuals Who Take HIV Preexposure Prophylaxis 1. In this cohort of individuals taking preexposure prophylaxis ...
#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Kidneys from donors with HIV have good safety outcomes in persons with HIV
1. Among patients living with human immunodeficiency virus (HIV) who received deceased donor kidney transplants, kidneys from donors with HIV ...
Kidney Transplantation from Donors with Human Immunodeficiency Virus (HIV) is Non-inferior to Donors Without HIV
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF or F/TAF
1. In this randomized controlled trial, among adolescent girls and young women, it was found that twice-yearly lenacapavir resulted in ...
